Showing 2111-2120 of 9592 results for "".
A Promising Pipeline
https://practicaldermatology.com/conferences/maui-derm-2022/a-promising-pipeline/20051/Joel L. Cohen, MD says he's excited about a number of devices he's currently investigating for a wide-variety of medical and aesthetic dermatologic treatments. From body contouring to acne to hair removal, Dr. Cohen shares insights on advancing technologies for several indications.Multidimensional Impact of Prurigo Nodularis
https://practicaldermatology.com/topics/atopic-dermatitis/multidimensional-impact-of-prurigo-nodularis/20048/Like most dermatologists, you may find it challenging to keep up with the rapid discoveries regarding inflammatory skin diseases and new developments in treatment. This informational webinar will provide updates on evolving areas of practice.Five strategies to make the most of prejuvenation-minded dermatology
https://practicaldermatology.com/topics/practice-management/five-strategies-to-make-the-most-of-prejuvenation-minded-dermatology/20042/Congratulations! You, as a practice, were experts in “prejuvenation” well before it was a buzzy term. It is one thing to have a menu of "prevention" and "rejuvenation" oriented services and expertise. It is quite another way to market those services and skills to satisfy the next-generation patient’Connecting with Industry
https://practicaldermatology.com/series/dermatology-education-foundation/connecting-with-industry/19990/Beyond offering attendees a chance to network with one another, Dermatology Education Foundations meetings are a chance for attendees and industry to interact. Wendy Cantrell, CRNP, DNP says it's great to learn from these knowledgeable representatives, plus an excellent time to tell them how they caScientifically Speaking: Diagnosing and Treating Hair Loss, Part 2
https://practicaldermatology.com/series/scientifically-speaking/scientifically-speaking-diagnosing-and-treating-hair-loss-part-2/19958/From PRP to surgical updates and long-standing interventions, there are many options to address hair loss. It's essential to know the risks and benefits of treatments, including combinations. Host Joel L. Cohen, MD discusses options for hair loss with Marc Avram, MD, Cheryl Burgess, MD, and Reena JoDermWireTV: Who's Injecting? Game on for Top Derm; Rhode Island is Sunucated
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-whos-injecting-game-on-for-top-derm-rhode-island-is-sunucated/19960/New data reveal who is providing cosmetic injections in dermatology and plastic surgery practices. Level Ex enters the dermatology specialty with Top Derm. More than half of all states are now Sunucated. And CSF is coming to Nashville.Gettin' Social With It
https://practicaldermatology.com/topics/practice-management/gettin-social-with-it/19728/An online presence is important, maybe even essential. But there are right and wrong ways to approach social media marketing. Joel Cohen, MD talks to Risa Luksa about the practices and pitfalls of social media.Surgery Not Required?
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/surgery-not-required/19723/Patients increasingly want non-surgical options for skin tightening. Fortunately, a plethora of highly effective options exist, from ultrasound to radiofrequency, according to Mitchel Goldman, MD.SCALE 2019: Meeting Highlights from Music City
https://practicaldermatology.com/topics/practice-management/scale-2019-meeting-highlights-from-music-city/19619/With an emphasis on both medical and cosmetic dermatology as well as practice management, Music City Scale or the Symposium for Cosmetic Advances and Laser Education has something for everyone, organizers says. Co-chairs Michael Gold, MD and Brian Biesman, MD are joined by several presenters to discUpdates from Principia, Sebacia, and Candela
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-updates-from-principia-sebacia-and-candela/19571/Phase 2 data for from the Believe-PV study for PRN1008 show that the investigational agent from Principia Biopharma reached the primary efficacy measure in pemphigus. Data confirm that Sebacia microparticles confer benefit in the management of acne vulgaris in real-world settings. Candela has rebran